Pharmafile Logo
Pharmafocus logo
Advanced Search
astrazeneca_building_white

AstraZeneca rejects “incorrect” claims about COVID-19 vaccine efficacy

January 26, 2021
Manufacturing and Production AstraZeneca, COVID-19

AstraZeneca has rejected claims by German media that its COVID-19 vaccine has only 8% efficacy in over-65s. Two German newspapers, …

News
merckincweb

MSD discontinues development of COVID-19 vaccines

January 26, 2021
Manufacturing and Production MSD, Merck

Merck, known as MSD outside of the US and Canada, has announced that the company is discontinuing development of its …

News
abbvie_0

AbbVie’s psoriatic arthritis and ankylosing spondylitis drug gets EU approval

January 26, 2021
Manufacturing and Production AbbVie

The European Commission (EC) has approved AbbVie’s RINVOQTM (upadacitinib 15 mg), an oral, once-daily selective and reversible JAK inhibitor for …

News
drug-trials

How COVID-19 has affected the oncology drugs market

January 25, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Cancer

In its disruption to clinical trials and drug supply to patients, the COVID-19 pandemic has impacted the most crucial areas …

Feature

NovAliX and Chemical.AI announce drug discovery collaboration

January 25, 2021
Sales and Marketing Chemical.AI, Novalix

NovAliX, a drug discovery-focused contract research organisation, and Chemical.AI, an artificial intelligence (AI) company, have announced a strategic collaboration in …

News
exelixis

FDA approves Exelixis’ cancer drug Cabometyx

January 25, 2021
Sales and Marketing Cancer, Exelixis

The FDA has approved Exelixis’ Cabometyx (cabozantinib) for patients with advanced renal cell carcinoma (RCC) as a first-line treatment in …

News
brain-1845962_960_720

New study challenges link between stress and migraines

January 25, 2021
Sales and Marketing Curelator, migraine

Digital health platform Curelator has announced new data that shows a lack of association between increased stress and migraine attacks. …

News
genentech_web

Genentech announces positive top-line results for “wet” age-related macular degeneration antibody

January 25, 2021
Sales and Marketing Genentech

Genentech has announced positive top-line results from two identically designed global Phase III studies, TENAYA and LUCERNE, evaluating its investigational …

News
mr058666-web

Merck KGaA’s cancer drug Bavencio gets EU approval

January 25, 2021
Sales and Marketing Merck KGaA

The EC has approved Merck KGaA’s BAVENCIO (avelumab) as monotherapy for the first-line maintenance treatment of adult patients with locally …

News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

January 22, 2021
Medical Communications

A number of Pharmafile.com’s most popular stories this week are surprisingly unrelated to COVID; researchers in Scotland have made a …

News

NICE rejects multiple sclerosis drug Zeposia

January 22, 2021
Medical Communications NICE

NICE has decided not to recommend Bristol Myers Squibb’s Zeposia (ozanimod) for the treatment of relapsing/remitting multiple sclerosis (RRMS). In …

News

Servier and MiNA partner to develop neurological disorder treatments

January 22, 2021
Medical Communications MiNA, Servier

Independent pharmaceutical group Servier and RNA activation-focused MiNA Therapeutics have entered a research partnership to identify and develop small activating …

News
lilly_building_with_american_flag_web

Lilly’s antibody could reduce COVID-19 risk by 80%, trial shows

January 22, 2021
Medical Communications COVID-19, Eli Lilly

Eli Lilly’s neutralising antibody bamlanivimab significantly reduced the risk of contracting symptomatic coronavirus among residents and staff of long-term care …

News
landing-hero-images1

ViiV’s long-acting HIV drug Cabenuva gets FDA approval

January 22, 2021
Medical Communications HIV, ViiV Healthcare

The FDA has approved ViiV’s Cabenuva, the first and only complete long-acting regimen for the treatment of HIV-1 infection in …

News
xellia

Xellia Pharmaceuticals becomes member of Medicines for Europe

January 21, 2021
Europe, xellia

Xellia Pharmaceuticals, a manufacturer of specialty anti-infective treatments, has become a member of Medicines for Europe. Medicines for Europe represents …

News
gsk_boronia_australia

GSK and Eligo enter acne research partnership

January 21, 2021
GlaxoSmithKilne, acne

Eligo Bioscience has entered into a research and option agreement with GlaxoSmithKline (GSK) aimed at advancing Eligobiotics for the treatment …

News
boehringer_biberach_germany_copy

Researchers and pharma companies partner to investigate new schizophrenia treatment

January 21, 2021
Biogen, Boehringer Ingelheim

The University of Oxford, the Earlham Institute, and global pharmaceutical companies Biogen and Boehringer Ingelheim are partnering to investigate a …

News

Thousands of Israelis test positive for COVID-19 after receiving Pfizer jab

January 21, 2021
COVID-19, Pfizer, israel

Thousands of people in Israel have tested positive for coronavirus after receiving the Pfizer vaccine, including some who had been …

News
gilead-sciences

NICE recommends rheumatoid arthritis drug Jyseleca for NHS use

January 21, 2021
Gilead, NICE

NICE has issued a final appraisal determination (FAD) recommending the use of Jyseleca (filgotinib) on the NHS in England for …

News
nicki_grundy

Raremark appoints Nicki Grundy as CFO

January 20, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Raremark, a global healthtech company specialising in rare disease, has appointed Nicki Grundy as Chief Financial Officer. As a key …

Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025